We are pleased to announce that Cardiolink has recently concluded a distribution agreement with Exthera Medical Corporation, a medical device company focused on therapeutic applications to treat drug-resistant and drug-susceptible bloodstream infections in high-risk patient populations, regarding its microbind affinity blood filter Seraph® 100. Seraph 100 is a single use extracorporeal broadspectrum sorbent hemoperfusion device [...]